AlphaYouFG
Insider buying
Faisal Ghiath Sukhtian bought $100K of Outlook Therapeutics, Inc. (OTLK) stock
Faisal Ghiath Sukhtian, Dir of Outlook Therapeutics, Inc. (OTLK), bought 95,398 shares of OTLK stock worth $100K, per an SEC Form 4 filed Jul 29, 2026.
It was an open-market purchase.
The trade was reported on Jul 29, 2026.
OTLK has moved -31.4% since the trade date, from $1.00 to $0.69 (Sep 21, 2026 close).
- Traded
- Jul 29, 2026
- Disclosed
- Jul 29, 2026
- Filing delay
- 0 days
- Price since
- -31.4%
- Role
- Dir
- Source
- SEC Form 4
More OTLK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.